Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-18 Option Award | 2024-11-19 4:05 pm | N/A 2034-11-17 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Chief Medical Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-08-05 Option Award | 2024-08-07 5:23 pm | N/A 2034-08-04 | ALX ONCOLOGY HOLDINGS INC | ALXO | Sandler Alan B. Director | 40,400 | $0 | 40,400 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:30 pm | N/A 2034-06-12 | Elevation Oncology Inc. | ELEV | Sandler Alan B. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-04 4:40 pm | N/A 2034-02-28 | Elevation Oncology Inc. | ELEV | Sandler Alan B. Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2024-01-23 Disposition | 2024-01-23 8:37 pm | N/A 2032-11-06 | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 144,865 | $0 | 0 (Direct) | View |
| 2023-12-29 Option Award | 2024-01-03 6:01 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 17,021 | $58.75 | 79,318 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-10 4:19 pm | N/A N/A | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 22,297 | $37 | 62,297 (Direct) | View |
| 2022-11-07 Option Award | 2022-11-08 6:00 pm | N/A 2032-11-06 | Mirati Therapeutics Inc. | MRTX | Sandler Alan B. Chief Medical Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-06-25 Option Award | 2022-06-27 9:44 pm | N/A N/A | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 73,000 | $0 | 73,000 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-05 4:05 pm | N/A N/A | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 1,060 | $0 | 137,616 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:05 pm | N/A 2032-04-01 | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 104,391 | $0 | 137,616 (Direct) | View |
| 2021-12-01 Tax Withholding | 2021-12-03 6:29 pm | N/A N/A | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 2,075 | $71.23 | 27,925 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 9:44 pm | N/A 2031-04-01 | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 33,300 | $0 | 33,300 (Direct) | View |
Ownership | 2021-01-04 07:34 am | N/A N/A | Zai Lab Ltd | ZLAB | Sandler Alan B. Head of Global Dev., Oncology | 0 | $0 | 77,000 (Direct) | View |